Emmaus Life Sciences, Inc. (EMMA)

Emmaus Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	29.6	29.6	18.39	20.61	23.17	22.75
Revenue Growth (YoY)	60.94%	60.94%	-10.77%	-11.04%	1.82%	1629.53%
Cost of Revenue	1.34	1.37	2.59	3.31	2.25	1.09
Gross Profit	28.26	28.22	15.8	17.3	20.92	21.66
Selling, General & Admin	23.53	23.49	20.66	19.32	18.54	23.99
Research & Development	1.19	1.19	1.73	4.11	2.41	2.18
Other Operating Expenses	0	0	-3.98	0	0	-3.34
Operating Expenses	24.72	24.68	22.39	23.43	20.95	26.17
Operating Income	3.54	3.54	-6.59	-6.13	-0.04	-4.51
Interest Income	0.68	0.68	0.68	0.76	2.3	0.23
Interest Expense	7.38	7.38	5.01	3.1	5.99	27.39
Other Expense / Income	0.63	0.63	-0.29	7.45	-4.7	23.01
Pretax Income	-3.79	-3.79	-10.63	-15.92	0.72	-54.68
Income Tax	-0.06	-0.06	0.06	0.03	-0.38	0.16
Net Income	-3.73	-3.73	-10.69	-15.95	1.35	-54.84
Shares Outstanding (Basic)	62	53	49	49	49	42
Shares Outstanding (Diluted)	62	53	49	49	49	42
Shares Change	24.73%	7.41%	0.38%	0.73%	15.71%	4776.49%
EPS (Basic)	-0.08	-0.07	-0.22	-0.32	0.03	-1.30
EPS (Diluted)	-0.08	-0.07	-0.22	-0.32	0.03	-1.30
Free Cash Flow	-1.52	-1.52	-5.1	-1.33	-28.63	-4.58
Free Cash Flow Per Share	-0.02	-0.03	-0.10	-0.03	-0.59	-0.11
Gross Margin	95.47%	95.36%	85.93%	83.93%	90.30%	95.19%
Operating Margin	11.96%	11.96%	-35.81%	-29.73%	-0.19%	-19.83%
Profit Margin	-12.61%	-12.61%	-58.10%	-77.37%	5.84%	-241.04%
Free Cash Flow Margin	-5.14%	-5.14%	-27.73%	-6.44%	-123.56%	-20.14%
Effective Tax Rate	-	-	-	-	-52.99%	-
EBITDA	3.1	3.57	-6.59	-8.04	0.02	-8.19
EBITDA Margin	10.46%	12.07%	-35.81%	-39.02%	0.07%	-36.01%
Depreciation & Amortization	0.03	0.03	0.05	0.06	0.06	0.07
EBIT	3.07	3.54	-6.64	-8.1	-0.04	-8.27
EBIT Margin	10.36%	11.96%	-36.10%	-39.30%	-0.19%	-36.34%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.